$4.10 (-0.243%)

Volume: 39.591k

Closed: Mar 28, 2023

Hollow Logo Score: -0.622
Capricor Therapeutics Stock
$4.10 (-0.243%)

Volume: 39.591k

Closed: Mar 28, 2023

Score Hollow Logo -0.622

Capricor Therapeutics Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-03-28 - 2023-03-28 HOLD 0
2023-03-24 - 2023-03-28 SELL -0.485
2023-03-23 - 2023-03-24 HOLD -1.67
2023-03-21 - 2023-03-23 SELL -4.77
2023-03-20 - 2023-03-21 BUY -1.79

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE